1 completed. 1 Phase 2.
| Phase | Trials | Status |
|---|---|---|
| Phase 2 | 1 | Completed 1 |
Follow Random Allocation: new trials by email Literature Review of Random Allocation trials Research Report on Random Allocation
Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.
| Trial | Phase | Status | Sponsor | Enrollment | Start | Updated |
|---|---|---|---|---|---|---|
| Study to Evaluate the Safety, PK, and Dose Response of Paltusotine in Subjects With Carcinoid Syndrome Randomized: 40 mg Paltusotine, Randomized: 80 mg Paltusotine - Carcinoid Syndrome, Carcinoid | Phase 2 | Completed | Crinetics Pharmaceuticals Inc. | 36 | 2022-04-22 | 2026-03-19 |
Carcinoid Tumor (1) · Carcinoid Tumors, Intestinal (1) · Neuroendocrine Tumors (1) · Serotonin Syndrome (1)
Crinetics Pharmaceuticals Inc. (1)
Argentina (1) · Brazil (1) · Canada (1) · Mexico (1) · Peru (1) · Poland (1) · United States (1)